PeerLogix (LOGX) Stock: This Announcement Changes The Game

PeerLogix LOGX Stock News

PeerLogix (OTC: LOGX) announced partnership news this morning that we believe greatly increases the value proposition posed by the company. In a press release, the company said that it has entered into a partnership agreement that will likely lead to meaningful revenue growth. Today, we’ll talk about: The partnership news; What we’re seeing from LOGX … Read more

Titan Pharmaceuticals (TTNP) Stock: Rocketing On Partnership News

Titan Pharmaceuticals TTNP Stock News

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is having a great day in the market today, and for good reason. The company announced a partnership, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The partnership news; what we’re seeing from TTNP stock as a result; and what we’ll be … Read more

Adial Pharmaceuticals (ADIL) Stock: Here’s What’s Happening

Adial Pharmaceutcials ADIL Stock News

Adial Pharmaceuticals Inc (NASDAQ: ADIL) is headed up in the market today with a couple bits of news that have come out in the past 24 hours or so. Yesterday, the company announced a partnership, followed up by some offering news this morning.  All of the news seems to be heading to a short squeeze, … Read more

Attis Industries (ATIS) Stock: Gaining Further On Sunoco Deal

Attis Industires ATIS Stock News

Attis Industries (NASDAQ: ATIS) is having yet another strong day in the market today, following up on the gains that we saw throughout last week. The gains today are the result of new information released by the company about the Sunoco facility acquisition that Sunoco announced on Friday. Today, we’ll talk about: The news; what we’re seeing … Read more

Biotech Stock News (RXII) (GNCA)

Rxi Pharmaceuticals (NASDAQ:RXII) On Thursday March 31, 2016 Rxi Pharmaceuticals announced that it had received a patent from the United States Patent and Trademark Office — USPTO — for the company’s sd-rxRNA technology platform that covers CTGF — Connective Tissue Growth Factor. In essence the patent covers the company’s lead clinical product RXI-109, which is … Read more